Johnson & Johnson (J&J) MedTech has reported a 4.8% growth in global sales in 2024, though it expects its 2025 outlook to ...

New documents clarify how the FDA plans to regulate AI-enabled devices, experts say, but several important questions remain ...

The MLV100 2025 Yearbook, featuring 100 MedTech Leading Voices worth following on LinkedIn in 2025, has just been released. This hand-curated guide highlights leaders worldwide who consistently ...

Boston Scientific Corporation (NYSE:BSX), a leading player in the medical technology sector, has been making significant ...

Sutter Health, OSF HealthCare, University Hospitals and others are entering expensive, long-term partnerships for key devices ...

Analysts discuss Johnson & Johnson's outlook, highlighting MedTech challenges, litigation risks, pipeline opportunities, and mixed performance across segments.

President Donald Trump has swiftly announced a series of executive orders that could impact the medech industry.

Johnson & Johnson (NYSE: JNJ) shares dipped slightly before hours today on fourth-quarter results that topped the consensus ...

The excitement is building as the Medical Technology Association of India (MTaI) prepares to host its flagship event, ...

Johnson & Johnson executives, on a Wednesday earnings call, did not provide a timeline for when U.S. Varipulse cases will ...

The company reported revenue of $22.5 billion and adjusted earnings of $2.04 per share, compared to the consensus estimates ...